对早餐的反应性低血糖反应是否存在个体间的差异? 一个复制的交叉试验
Javier T Gonzalez1,2, Lorenzo Lolli3, Rachel C Veasey4
1Centre for Nutrition, Exercise and Metabolism, University of Bath, Bath, UK. J.T.Gonzalez@bath.ac.uk.
European journal of nutrition
|September 4, 2024
概括
这项研究发现,虽然反应性低血糖症发生在早餐后,但在早餐后仍存在.
科学领域:
- 对食物的代谢反应.
- 人类生理学 人类生理学
- 营养科学 营养科学
背景情况:
- 反应性低血糖症,即饭后血糖水平下降,是一种已知的现象.
- 这种反应的个体间差异以前没有被研究过.
研究的目的:
- 为了研究早餐后反应性低血糖症的个体间变异性.
- 分析葡萄糖,胰岛素和其他代谢标记物,以应对标准化的早餐.
主要方法:
- 一个复制的交叉设计与12名健康的男性 (18-30岁).
- 参与者吃了一顿标准的早餐 (444卡路里) 或是禁食.
- 测量血糖,乳酸盐,胰岛素,NEFA,能量消耗,基质氧化和食欲.
主要成果:
- 早餐降低了2小时的血糖和NEFA,并增加了乳酸和胰岛素 (p < 0.01).
- 在复制品之间发现了胰岛素,乳酸盐,饥饿和满意度反应的显著相关性.
- 在2小时胰岛素反应中,个体间的变化是显著的 (SD 11 pmol/L).
结论:
- 在群体层面上,没有发现反应性低血糖症的有意义的个体间变异.
- 在早餐的2小时胰岛素反应中存在显著的个体间变异.
- 这种变化可能与碳水化合物摄入量和个人胰岛素敏感性有关.
更多相关视频
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
1.1K
04:54Using a Combination of Indirect Calorimetry, Infrared Thermography, and Blood Glucose Levels to Measure Brown Adipose Tissue Thermogenesis in Humans
Published on: June 2, 2023
1.3K
相关概念视频
Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
Hypoglycemia and Glucagon
217
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
217
Oral Hypoglycemic Agents: Glinides
148
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
148
Glucose Homeostasis: Regulation of Blood Glucose
1.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.5K
